Clinical Trials Directory

Trials / Completed

CompletedNCT03885999

Studies in Patients With Low Anterior Resection Syndrome (LARS)

Functional Anorectal Studies in Patients With Low Anterior Resection Syndrome (LARS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Giome · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Colorectal Cancer is the commonest cancer diagnosed for both genders combined in Hong Kong. In 2015 16.6% of all new cancer cases registered on the Hong Kong registry were cancer of colon and rectum. With recent development in oncological and surgical treatments for rectal cancer, many patients are receiving sphincter-preserving surgery with low colorectal or coloanal anastomosis to avoid permanent stoma. Up to 80% of patients who has undergone low anterior resection (LAR), suffer from severe bowel dysfunction post operatively. Patients may suffer from a wide range of symptoms from incontinence, frequency, and urgency to constipation and feelings of incomplete emptying. This combination of symptoms after LAR is referred to as Low Anterior Resection Syndrome (LARS) which is associated with negative impact on quality of life (QoL). Originally, it was thought that these symptoms were due to early postoperative changes. Many studies report that the majority of patients experience longterm changes in quality of life after LAR. Therefore, a large number of patients worldwide are suffering from unpredictable, poor bowel function postoperatively affecting their day-to-day activity and quality of life. The cause of LARS is often multifactorial and difficult to define. Unfortunately, there is no cure for LARS at present. This trial is designed to use Fecobionics, a new Hong Kong based innovation of a simulated stool, to provide new mechanistic insights regarding anorectal physiological function post low anterior resection to understand the condition better to improve their treatment options.

Conditions

Interventions

TypeNameDescription
DEVICEFecobionicsFecobionics is a new device for studying defecation

Timeline

Start date
2019-05-29
Primary completion
2020-02-01
Completion
2020-03-01
First posted
2019-03-22
Last updated
2022-01-19
Results posted
2022-01-19

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03885999. Inclusion in this directory is not an endorsement.